JPRN-UMIN000030363已完成1 期
A preliminary open-labeled pharmacokinetic study to examine the effect of cilastatin on the prevention of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapy - A preliminary open-labeled pharmacokinetic study to examine the effect of cilastatin on the prevention of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapy
Department of Applied Molecular Medicine, Kidney Research Center, Niigata University Graduate School of Medical and Dental Science0 个研究点目标入组 9 人开始时间: 2017年12月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Those with kidney dysfunction (eGFR<60 mL/min/1.73m2) 2. Those who have diseases or symptoms considered to have an effect on the determination of efficacy or safety 3. Those who received antibiotics, antiviral drugs, or antifungal drugs (except for topical application, eye drops, or nose drops) within 14 days before enrollment 4. Those who are considered not eligible for this study by attending doctors due to any medical reasons
研究者
相似试验
已完成
1 期
A preliminary open-labeled pharmacokinetic study to examine the effect of cilastatin on the prevention of acute kidney injury in cancer patients undergoing cisplatin-based chemotherapyon small cell lung cancerJPRN-jRCTs031180329Saito Akihiko9
进行中（未招募）
不适用
A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (= 12 to = 17 Years of Age ) with Psoriasis - Tacrolimus Cream B 0.1% in AdolescentsEUCTR2006-002738-39-LVAstelleas Pharma US, Inc.20
终止
1 期
A Phase 1 study dosing with a Humira® (adalimumab) Enema in Patients with Active Ulcerative Colitis.lcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonUlcerative colitisACTRN12620000932965Progenity Inc4
进行中（未招募）
1 期
A clinical trial to find out how much tapentadol is in the blood of children who take tapentadol every 4 hours to treat short-term paiEUCTR2019-000205-77-PLGrünenthal GmbH15
已完成
不适用
An open-label study to assess the pharmacokinetics and safety/tolerability of pulsatile intra-vaginal delivery of a single dose of oxybutynin in healthy femalesNL-OMON51105iGalli BV8